Danaher Corporation $DHR Shares Sold by Aberdeen Group plc

Aberdeen Group plc decreased its position in Danaher Corporation (NYSE:DHR) by 0.4% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,153,731 shares of the conglomerate’s stock after selling 5,166 shares during the quarter. Aberdeen Group plc owned 0.16% of Danaher worth $221,170,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. WFA of San Diego LLC purchased a new position in shares of Danaher during the second quarter worth approximately $26,000. Howard Hughes Medical Institute acquired a new stake in shares of Danaher in the second quarter valued at approximately $27,000. TruNorth Capital Management LLC purchased a new position in Danaher in the 3rd quarter valued at about $28,000. Tripletail Wealth Management LLC acquired a new position in Danaher in the third quarter valued at $31,000. Finally, Heartwood Wealth Advisors LLC purchased a new stake in shares of Danaher during the 3rd quarter valued at $37,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Danaher Trading Down 1.2%

Shares of Danaher stock opened at $212.37 on Friday. The company has a 50-day simple moving average of $228.63 and a 200 day simple moving average of $215.52. The company has a quick ratio of 1.51, a current ratio of 1.87 and a debt-to-equity ratio of 0.35. The stock has a market capitalization of $150.01 billion, a P/E ratio of 42.14, a price-to-earnings-growth ratio of 2.87 and a beta of 0.91. Danaher Corporation has a 12-month low of $171.00 and a 12-month high of $242.80.

Danaher (NYSE:DHR) last released its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. The business had revenue of $6.84 billion during the quarter, compared to analysts’ expectations of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The firm’s revenue for the quarter was up 4.6% compared to the same quarter last year. During the same period in the previous year, the business posted $2.14 earnings per share. Research analysts expect that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, January 30th. Investors of record on Friday, December 26th were given a $0.32 dividend. This represents a $1.28 dividend on an annualized basis and a dividend yield of 0.6%. The ex-dividend date was Friday, December 26th. Danaher’s dividend payout ratio (DPR) is currently 25.40%.

Wall Street Analysts Forecast Growth

Several equities analysts recently commented on the company. HSBC boosted their price target on Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a research report on Monday, December 1st. Wall Street Zen upgraded shares of Danaher from a “hold” rating to a “buy” rating in a research note on Saturday, November 22nd. Argus set a $265.00 price target on shares of Danaher in a research report on Wednesday, January 14th. Guggenheim upped their price target on Danaher from $250.00 to $275.00 and gave the company a “buy” rating in a research report on Friday, January 2nd. Finally, Evercore reissued an “outperform” rating and issued a $254.00 target price on shares of Danaher in a research report on Wednesday, January 28th. Twenty analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $253.86.

Insider Activity

In other news, Director Teri List sold 3,298 shares of the firm’s stock in a transaction dated Tuesday, November 18th. The stock was sold at an average price of $226.50, for a total transaction of $746,997.00. Following the sale, the director owned 20,762 shares of the company’s stock, valued at $4,702,593. This trade represents a 13.71% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 11.10% of the stock is owned by company insiders.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.